Details of the Drug Combinations

General Information of This Drug (ID: DMG6OYJ)

Drug Name

Lorcaserin DMG6OYJ

Synonyms

APD 356; APD356; AR-10A; (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-benzo[d]azepine; 10-chloro-2-methyl-4-azabicyclo[5.4.0]undeca-8,10,12-triene

Indication

Disease Entry	ICD 11	Status	REF
Obesity	5B81	Approved	[1]
Drug abuse	6C4G.1Z	Phase 1	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

2 Clinical Trial Drug Combination(s) Consisting of This drug

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
Lorcaserin + Varenicline	DCJ8CV6	Varenicline	Tobacco Use Disorder	[2]
Lorcaserin + Varenicline	DC3Q0DF	Varenicline	Obesity	[3]
------------------------------------------------------------------------------------

References

1	URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2941).
2	ClinicalTrials.gov (NCT02393547) Lorcaserin for Preventing Weight Gain Among Smokers
3	ClinicalTrials.gov (NCT02412631) Addressing Post Cessation Weight Gain